Zomer E - Search Results

1

The impact of diabetes on productivity in China.

Hird TR, Zomer E, Owen A, Chen L, Ademi Z, Magliano DJ, Liew D. Hird TR, et al. Among authors: zomer e. Diabetologia. 2019 Jul;62(7):1195-1203. doi: 10.1007/s00125-019-4875-4. Epub 2019 Apr 27. Diabetologia. 2019. PMID: 31030220

2

Validation of two Framingham cardiovascular risk prediction algorithms in an Australian population: the 'old' versus the 'new' Framingham equation.

Zomer E, Owen A, Magliano DJ, Liew D, Reid C. Zomer E, et al. Eur J Cardiovasc Prev Rehabil. 2011 Feb;18(1):115-20. doi: 10.1097/HJR.0b013e32833ace24. Eur J Cardiovasc Prev Rehabil. 2011. PMID: 20473180

3

Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.

Zomer E, Liew D, Owen A, Magliano DJ, Ademi Z, Reid CM. Zomer E, et al. Eur J Prev Cardiol. 2014 Mar;21(3):384-90. doi: 10.1177/2047487312449307. Epub 2012 May 15. Eur J Prev Cardiol. 2014. PMID: 22588087

4

The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model.

Zomer E, Owen A, Magliano DJ, Liew D, Reid CM. Zomer E, et al. BMJ. 2012 May 30;344:e3657. doi: 10.1136/bmj.e3657. BMJ. 2012. PMID: 22653982 Free PMC article.

5

Overview of pharmacoeconomic modelling methods.

Ademi Z, Kim H, Zomer E, Reid CM, Hollingsworth B, Liew D. Ademi Z, et al. Among authors: zomer e. Br J Clin Pharmacol. 2013 Apr;75(4):944-50. doi: 10.1111/j.1365-2125.2012.04421.x. Br J Clin Pharmacol. 2013. PMID: 22882459 Free PMC article. Review.

6

Statins for people at low risk of cardiovascular disease.

Zomer E, Owen AJ, Magliano DJ, Reid CM. Zomer E, et al. Lancet. 2012 Nov 24;380(9856):1817; author reply 1817-8. doi: 10.1016/S0140-6736(12)62026-1. Lancet. 2012. PMID: 23177699 No abstract available.

7

Outcomes and excess costs among patients with cardiovascular disease.

Ademi Z, Liew D, Zomer E, Gorelik A, Hollingsworth B, Steg PG, Bhatt DL, Reid CM. Ademi Z, et al. Among authors: zomer e. Heart Lung Circ. 2013 Sep;22(9):724-30. doi: 10.1016/j.hlc.2013.02.002. Epub 2013 Mar 17. Heart Lung Circ. 2013. PMID: 23510668 Clinical Trial.

8

Predicting the impact of polypill use in a metabolic syndrome population: an effectiveness and cost-effectiveness analysis.

Zomer E, Owen A, Magliano DJ, Ademi Z, Reid CM, Liew D. Zomer E, et al. Am J Cardiovasc Drugs. 2013 Apr;13(2):121-8. doi: 10.1007/s40256-013-0019-2. Am J Cardiovasc Drugs. 2013. PMID: 23532687

9

Predictors of health care use among patients with or at high risk of atherothrombotic disease: two-year follow-up data.

Ademi Z, Liew D, Gorelik A, Bohensky M, Zomer E, Hollingsworth B, Steg G, Bhatt DL, Reid CM; REACH Registry investigators. Ademi Z, et al. Among authors: zomer e. Int J Cardiol. 2014 Jul 15;175(1):72-7. doi: 10.1016/j.ijcard.2014.04.230. Epub 2014 Apr 28. Int J Cardiol. 2014. PMID: 24816526

10

Can oral vitamin D prevent the cardiovascular diseases among migrants in Australia? Provider perspective using Markov modelling.

Ruwanpathirana T, Owen A, Renzaho AM, Zomer E, Gambhir M, Reid CM. Ruwanpathirana T, et al. Among authors: zomer e. Clin Exp Pharmacol Physiol. 2015 Jun;42(6):596-601. doi: 10.1111/1440-1681.12399. Clin Exp Pharmacol Physiol. 2015. PMID: 25854647

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

116 results

Search Page